Key terms

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ZBH news

Apr 17 3:59am ET RBC Capital Sticks to Their Buy Rating for Zimmer Biomet Holdings (ZBH) Apr 04 7:36am ET Zimmer Biomet becomes official medical device partner of U.S. pickleball Apr 03 5:53am ET Zimmer Biomet price target raised to $140 from $134 at Citi Mar 07 7:30am ET Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and Zimmer Biomet Holdings (ZBH) Mar 04 9:17am ET Zimmer Biomet price target raised to $129 from $120 at Roth MKM Feb 23 7:36am ET Zimmer Biomet Holdings: A Cautious Hold Amidst Gradual Market Adoption of ROSA Shoulder System Feb 22 10:55am ET Zimmer Biomet Holdings: Hold Rating Maintained Amid Innovative Growth Opportunities Feb 22 7:33am ET Zimmer Biomet receives FDA clearance for ROSA Shoulder System Feb 21 7:25am ET BTIG medical technology analyst to hold analyst/industry conference call Feb 21 4:55am ET BTIG medical technology analyst to hold analyst/industry conference call Feb 16 5:22am ET Zimmer Biomet Holdings: Assessing the Impact of Stabilizing Prices on Market Performance Feb 15 12:57pm ET BTIG medical technology analyst to hold analyst/industry conference call Feb 14 5:31pm ET Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH) and Antibe Therapeutics (OtherATBPF) Feb 12 7:31am ET Zimmer Biomet signs Global Health Equity Network’s Zero Health Gaps Pledge Feb 11 12:11pm ET Zimmer Biomet price target raised to $130 from $120 at Barclays Feb 11 11:46am ET Sell Rating on Zimmer Biomet Holdings Amid Growth and Margin Challenges Feb 09 9:20am ET Zimmer Biomet price target lowered to $140 from $147 at Deutsche Bank Feb 09 8:20am ET Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), BioNTech SE (BNTX) and Zimmer Biomet Holdings (ZBH) Feb 09 7:40am ET Zimmer Biomet price target raised to $132 from $119 at Wells Fargo Feb 09 7:22am ET Analysts Are Bullish on Top Healthcare Stocks: Zimmer Biomet Holdings (ZBH), Illumina (ILMN) Feb 09 6:28am ET Citi opens ‘positive catalyst watch’ on Zimmer Biomet into AAOS Feb 09 6:26am ET Zimmer Biomet price target raised to $155 from $149 at Baird Feb 09 12:25am ET Buy Rating Affirmed for Zimmer Biomet Holdings on Strong Q4 Performance and Positive 2024 Outlook Feb 08 8:01pm ET Analysts Offer Insights on Healthcare Companies: Alector (ALEC), Viking Therapeutics (VKTX) and Zimmer Biomet Holdings (ZBH) Feb 08 7:46pm ET Neutral Hold Rating for Zimmer Biomet Holdings Amidst Mixed Performance and Conservative Outlook Feb 08 7:45pm ET Zimmer Biomet Holdings: Hold Rating with Modest Growth and Marginal Pressure Anticipated Feb 08 4:25pm ET Maintaining Hold: Zimmer Biomet’s Steady Growth Outlook Balanced with Current Valuation Feb 08 3:15pm ET Needham Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH) Feb 08 6:42am ET Zimmer Biomet sees FY24 adjusted EPS $8.00-$8.15, consensus $7.94 Feb 08 6:40am ET Zimmer Biomet reports Q4 EPS $2.20, consensus $2.15 Feb 07 8:25pm ET Notable companies reporting before tomorrow’s open

No recent press releases are available for ZBH

ZBH Financials

1-year income & revenue

Key terms

ZBH Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ZBH Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms